← Back to Investors

Novo Holdings

Novo Holdings is the holding and investment company of the Novo Nordisk Foundation, one of the world's largest philanthropic foundations. They are among the largest life sciences investors globally, investing across venture, growth equity, principal investments, and public equities in healthcare.

Location
Hellerup, Denmark
Founded
1999
AUM
$150B+
Investment Range
$10M - $500M+
Portfolio Companies
13
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
Booster TherapeuticsCopenhagen, Denmark2024
biotechtherapeutics+3
Obsidian TherapeuticsCambridge, Massachusetts, USA2015
biotechcell-therapy+2
AvenCell TherapeuticsBerlin, Germany2019
biotechcell-therapy+3
Convergent TherapeuticsNew York, New York, USA2021
therapeuticsbiotech+3
Myricx BioLondon, United Kingdom2019
therapeuticsbiotech+3
AsceneuronLausanne, Switzerland2012
biotechneuroscience+3
MedGenomeBangalore, India & Foster City, California, USA2013
genomics-sequencingdiagnostics+3
Sangon BiotechShanghai, China2001
genomics-sequencingbiotech+2
Oxford Nanopore TechnologiesOxford, United Kingdom2005
genomics-sequencingbiotech+2
Kivu BiosciencesBoston, Massachusetts, USA2021
biotechtherapeutics+2
SiteOne TherapeuticsBozeman, Montana, USA2014
biotechtherapeutics+3
ArriVent BioPharmaIrvine, California, USA2021
biotechoncology+3
Zenas BioPharmaWaltham, Massachusetts, USA2021
biotechtherapeutics+2